Opposing roles of corticotropin-releasing factor and neuropeptide Y within the dorsolateral bed nucleus of the stria terminalis in the negative affective component of pain in rats

Journal of Neuroscience

Volumn 33, Issue 14, 2013, Pages 5881-5894

  Ide, Soichiro ^a   Hara, Taiki ^a   Ohno, Atsushi ^a   Tamano, Ryuta ^a   Koseki, Kana ^a   Naka, Tomonori ^a   Maruyama, Chikashi ^a   Kaneda, Katsuyuki ^a   Yoshioka, Mitsuhiro ^b   Minami, Masabumi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 CHLORO 4 [N (CYCLOPROPYLMETHYL) N PROPYLAMINO] 2 METHYL 6 (2, 4, 6 TRICHLOROANILINO) PYRIMIDINE; ANTISAUVAGINE 30; CORTICOTROPIN RELEASING FACTOR; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AVERSION; BEHAVIOR; CONDITIONING; CONDUCTANCE; CONTROLLED STUDY; DEPOLARIZATION; ELECTROPHYSIOLOGY; ENZYME IMMUNOASSAY; HISTOLOGY; MALE; MEMBRANE POTENTIAL; MICRODIALYSIS; MICROINJECTION; NERVE EXCITABILITY; NOCICEPTION; NOCICEPTIVE PAIN; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; SPIKE WAVE; STEADY STATE; STRIA TERMINALIS;

ACTION POTENTIALS; AFFECTIVE SYMPTOMS; ANALYSIS OF VARIANCE; ANILINE COMPOUNDS; ANIMALS; ARGININE; CORTICOTROPIN-RELEASING HORMONE; CYCLOHEXANES; DISEASE MODELS, ANIMAL; EXCITATORY AMINO ACID ANTAGONISTS; FORMALDEHYDE; GABA ANTAGONISTS; HORMONE ANTAGONISTS; HORMONES; KYNURENIC ACID; MALE; MEMBRANE POTENTIALS; MICRODIALYSIS; NEURONS; NEUROPEPTIDE Y; PAIN; PAIN MEASUREMENT; PEPTIDE FRAGMENTS; PYRIDAZINES; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; SEPTAL NUCLEI; XANTHENES;

EID: 84875988022     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4278-12.2013     Document Type: Article

References (44)

1. Bale TL, ValeWW (2004) CRF and CRF receptors: role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol 44:525-557. CrossRef Medline
2. Deyama S, Nakagawa T, Kaneko S, Uehara T, Minami M (2007) Involvement of the bed nucleus of the stria terminalis in the negative affective component of visceral and somatic pain in rats. Behav Brain Res 176:367-371. CrossRef Medline
3. Deyama S, Katayama T, Ohno A, Nakagawa T, Kaneko S, Yamaguchi T, Yoshioka M, Minami M (2008) Activation of the β-adrenoceptorprotein kinase A signaling pathway within the ventral bed nucleus of the stria terminalis mediates the negative affective component of pain in rats. J Neurosci 28:7728-7736. CrossRef Medline
4. Deyama S, Katayama T, Kondoh N, Nakagawa T, Kaneko S, Yamaguchi T, Yoshioka M, Minami M (2009) Role of enhanced noradrenergic transmission within the ventral bed nucleus of the stria terminalis in visceral pain-induced aversion in rats. Behav Brain Res 197:279-283. CrossRef Medline
5. Deyama S, Ide S, Kondoh N, Yamaguchi T, Yoshioka M, Minami M (2011) Inhibition of noradrenaline release by clonidine in the ventral bed nucleus of the stria terminalis attenuates pain-induced aversion in rats. Neuropharmacology 61:156-160. CrossRef Medline
6. Dumont EC, Williams JT (2004) Noradrenaline triggers GABAA inhibition of bed nucleus of the stria terminalis neurons projecting to the ventral tegmental area. J Neurosci 24:8198-8204. CrossRef Medline
7. Georges F, Aston-Jones G (2001) Potent regulation of midbrain dopamine neurons by the bed nucleus of the stria terminalis. J Neurosci 21:RC160. Medline
8. Georges F, Aston-Jones G (2002) Activation of ventral tegmental area cells by the bed nucleus of the stria terminalis: a novel excitatory amino acid input to midbrain dopamine neurons. J Neurosci 22:5173-5187. Medline
9. Giesbrecht CJ, Mackay JP, Silveira HB, Urban JH, Colmers WF (2010) Countervailing modulation of Ih by neuropeptide Y and corticotrophinreleasing factor in basolateral amygdala as a possible mechanism for their effects on stress-related behaviors. J Neurosci 30:16970-16982. CrossRef Medline
10. Gutman AR, Yang Y, Ressler KJ, DavisM (2008) The role of neuropeptide Y in the expression and extinction of fear-potentiated startle. J Neurosci 28:12682-12690. CrossRef Medline
11. Hammack SE, Mania I, RainnieDG (2007) Differential expression of intrinsic membrane currents in defined cell types of the anterolateral bed nucleus of the stria terminalis. J Neurophysiol 98:638-656. CrossRef Medline
12. + current in guinea-pig atrial cells. Eur J Pharmacol 324:295-303. CrossRef Medline
13. HeiligM (1995) Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding. Regul Pept 59:201-205. CrossRef Medline
14. Ito K, Dulon D (2002) Nonselective cation conductance activated by muscarinic and purinergic receptors in rat spiral ganglion neurons. Am J Physiol Cell Physiol 282:C1121-1135. Medline
15. Jedema HP, Grace AA (2004) Corticotropin-releasing hormone directly activates noradrenergic neurons of the locus ceruleus recorded in vitro. J Neurosci 24:9703-9713. CrossRef Medline
16. Johansen JP, Fields HL (2004) Glutamatergic activation of anterior cingulate cortex produces an aversive teaching signal. Nat Neurosci 7:398-403. CrossRef Medline
17. Johansen JP, Fields HL, Manning BH (2001) The affective component of pain in rodents: direct evidence for a contribution of the anterior cingulate cortex. Proc Natl Acad Sci U S A 98:8077-8082. CrossRef Medline
18. + conductance: a study using glutamate decarboxylase 67-green fluorescent protein knock-in mice. Neuroscience 157: 781-797. CrossRef Medline
19. Kash TL, Winder DG (2006) Neuropeptide Y and corticotropin-releasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis. Neuropharmacology 51:1013-1022. CrossRef Medline
20. Kask A, Rägo L, Harro J (1997) Alpha-helical CRF(9-41) prevents anxiogenic-like effect of NPY Y1 receptor antagonist BIBP3226 in rats. Neuroreport 8:3645-3647. CrossRef Medline
21. Kosten TA (1994) Clonidine attenuates conditioned aversion produced by naloxone-precipitated opiate withdrawal. Eur J Pharmacol 254:59-63. CrossRef Medline
22. Kudo T, Uchigashima M, Miyazaki T, Konno K, Yamasaki M, Yanagawa Y, Minami M, Watanabe M (2012) Three types of neurochemical projection from the bed nucleus of the stria terminalis to the ventral tegmental area in adult mice. J Neurosci 32:18035-18046. CrossRef Medline
23. Lee Y, DavisM (1997) Role of the hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropinreleasing hormone on the acoustic startle reflex. J Neurosci 17:6434-6446. Medline
24. Morin SM, Ling N, Liu XJ, Kahl SD, Gehlert DR (1999) Differential distribution of urocortin-and corticotropin-releasing factor-like immunoreactivities in the rat brain. Neuroscience 92:281-291. CrossRef Medline
25. + channels in isolated locus coeruleus neurons. Neurosci Res 51:55-65. CrossRef Medline
26. Nakagawa T, Yamamoto R, Fujio M, Suzuki Y, Minami M, Satoh M, Kaneko S (2005) Involvement of the bed nucleus of the stria terminalis activated by the central nucleus of the amygdala in the negative affective component of morphine withdrawal in rats. Neuroscience 134:9-19. CrossRef Medline
27. Nakajima M, Inui A, Asakawa A, Momose K, Ueno N, Teranishi A, Baba S, Kasuga M (1998) Neuropeptide Y produces anxiety via Y2-type receptors. Peptides 19:359-363. CrossRef Medline
28. Parker RM, Herzog H (1999) Regional distribution of Y-receptor subtype mRNAs in rat brain. Eur J Neurosci 11:1431-1448. CrossRef Medline
29. Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates, Ed 4. San Diego, CA: Academic.
30. Primeaux SD, Wilson SP, Cusick MC, York DA, Wilson MA (2005) Effects of altered amygdalar neuropeptide Y expression on anxiety-related behaviors. Neuropsychopharmacology 30:1589-1597. CrossRef Medline
31. Rafieian-Kopaei M, Gray AM, Spencer PS, Sewell RD (1995) Contrasting actions of acute or chronic paroxetine and fluvoxamine on morphine withdrawal-induced place conditioning. Eur J Pharmacol 275:185-189. CrossRef Medline
32. Sahuque LL, Kullberg EF, Mcgeehan AJ, Kinder JR, Hicks MP, Blanton MG, Janak PH, Olive MF (2006) Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes. Psychopharmacology 186: 122-132. CrossRef Medline
33. Sajdyk TJ, Schober DA, Smiley DL, Gehlert DR (2002) Neuropeptide Y-Y2 receptors mediate anxiety in the amygdala. Pharmacol Biochem Behav 71:419-423. CrossRef Medline
34. Sajdyk TJ, Fitz SD, Shekhar A (2006) The role of neuropeptide Y in the amygdala on corticotropin-releasing factor receptor-mediated behavioral stress responses in the rat. Stress 9:21-28. CrossRef Medline
35. Sakanaka M, Shibasaki T, Lederis K (1986) Distribution and efferent projections of corticotropin-releasing factor-like immunoreactivity in the rat amygdaloid complex. Brain Res 382:213-238. CrossRef Medline
36. Sørensen G, Lindberg C, Wörtwein G, Bolwig TG, Woldbye DP (2004) Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation. J Neurosci Res 77:723-729. CrossRef Medline
37. Takahashi LK (2001) Role of CRF1 and CRF2 receptors in fear and anxiety. Neurosci Biobehav Rev 25:627-636. CrossRef Medline
38. Takano K, Yasufuku-Takano J, Teramoto A, Fujita T (1996) Corticotropinreleasing hormone excites adrenocorticotropin-secreting human pituitary adenoma cells by activating a nonselective cation current. J Clin Invest 98:2033-2041. CrossRef Medline
39. Tan KR, Yvon C, Turiault M, Mirzabekov JJ, Doehner J, Labouèbe G, Deisseroth K, Tye KM, Lüscher C (2012) GABA neurons of the VTA drive conditioned place aversion. Neuron 73:1173-1183. CrossRef Medline
40. Tanimoto S, Nakagawa T, Yamauchi Y, Minami M, SatohM (2003) Differential contributions of the basolateral and central nuclei of the amygdala in the negative affective component of chemical somatic and visceral pains in rats. Eur J Neurosci 18:2343-2350. CrossRef Medline
41. Tzschentke TM (1998) Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol 56:613-672. CrossRef Medline
42. Van Pett K, Viau V, Bittencourt JC, Chan RK, Li HY, Arias C, Prins GS, Perrin M, Vale W, Sawchenko PE (2000) Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 428:191-212. CrossRef Medline
43. Walter A, Mai JK, Lanta L, Görcs T (1991) Differential distribution of immunohistochemical markers in the bed nucleus of the stria terminalis in the human brain. J Chem Neuroanat 4:281-298. CrossRef Medline
44. Yang B, Ferguson AV (2002) Orexin-A depolarizes dissociated rat area postrema neurons through activation of a nonselective cationic conductance. J Neurosci 22:6303-6308. Medline